Global Chemotherapy Induced Peripheral Neuropathy Treatment Market
Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024, Featuring Sanofi, Bristol Myers Squibb, Abbott Laboratories, Takeda Pharmaceutical and Amgen
March 08, 2024 04:28 ET | Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The chemotherapy...
22157.jpg
Global PRMT5 Targeted Therapy Market & Clinical Trials Insights 2024: Innovation and Potential in Oncology and Beyond
February 29, 2024 04:06 ET | Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Global PRMT5 Targeted Therapy Market & Clinical Trials Opportunity Outlook 2024" report has been added to ResearchAndMarkets.com's offering. ...
Chinese Oncology Drugs Market
China Oncology Drugs Market Report, 2023 and 2024-2028 - Cancer Prevention Takes Center Stage in China's National Health Agenda
February 19, 2024 07:48 ET | Research and Markets
Dublin, Feb. 19, 2024 (GLOBE NEWSWIRE) -- The "China Oncology Drugs Market, Size, Forecast 2024-2028, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been...
Global Head and Neck Cancer Therapeutics Market
Head and Neck Cancer Therapeutics Market to Reach $2.3 Billion by 2027 - New Research Report Reveals
January 24, 2024 13:26 ET | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Head and Neck Cancer Therapeutics Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The latest research report...
22157.jpg
Global Thyroid Cancer Drugs Market Report 2024: Highlights Trends in Targeted Therapies, Featuring Profiles of Mylan Pharmaceuticals, AstraZeneca, Exelixis, Pfizer, and Bristol-Myers Squibb
January 23, 2024 15:28 ET | Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Thyroid Cancer Drugs Global Market 2024" report has been added to ResearchAndMarkets.com's offering. The global thyroid cancer drugs market...
Global Chemotherapy Induced Peripheral Neuropathy Market
Chemotherapy Induced Peripheral Neuropathy Treatment Market to Surge to $2.06 Billion by 2027, New Research Shows
January 23, 2024 02:38 ET | Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The...
22157.jpg
Comprehensive Analysis of the Global Chemotherapy Market, 2018-2033: Digital Health and AI are Revolutionizing Cancer Care
January 18, 2024 06:58 ET | Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global chemotherapy market has grown rapidly in...
Ivo Timmermans
Pleco Therapeutics receives FDA Orphan Drug Designation
January 16, 2024 11:30 ET | Pleco Therapeutics B.V.
The U.S Food and Drug Administration (FDA) has granted Orphan Drug Designation to Pleco Therapeutics BV’s lead compound, PTX-252 for the treatment of AML.
finacialnews-logo-final-01 (2).png
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
January 09, 2024 10:25 ET | FN Media Group LLC
PALM BEACH, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - According to the report titled "Aging in the United States," published by the Population Reference Bureau, "the...
Largest study to dat
Largest study to date of high-dose methotrexate associated acute kidney injury supports the use of Voraxaze® (glucarpidase)
December 11, 2023 09:51 ET | BTG Specialty Pharmaceuticals
West Conshohocken, PA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- BTG Pharmaceuticals, a SERB company, announces the presentation of the largest study to date of patients with high-dose methotrexate (HDMTX)...